Skip to Content

TEVA 3145 (Cephalexin Monohydrate 250 mg)

Pill with imprint TEVA 3145 is Gray / Orange, Capsule-shape and has been identified as Cephalexin Monohydrate 250 mg. It is supplied by Teva Pharmaceuticals USA.

Cephalexin is used in the treatment of bacterial infection; bladder infection; bacterial endocarditis prevention; bone infection; kidney infections and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Cephalexin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 3145

Cephalexin monohydrate 250 mg TEVA 3145
Cephalexin monohydrate 250 mg TEVA 3145
Cephalexin monohydrate 250 mg TEVA 3145
Cephalexin monohydrate 250 mg TEVA 3145

Cephalexin Monohydrate

Imprint
TEVA 3145
Strength
250 mg
Color
Gray / Orange
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
First generation cephalosporins
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-3145

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.